GLP-1 (Glucagon-Like Peptide 1)

The GLP-1 (Glucagon-Like Peptide 1) chart explains how GLP-1 receptor agonists work in the body to regulate blood sugar, support weight management, and treat type 2 diabetes. It illustrates GLP-1’s effects on the pancreas, stomach, brain, and cardiovascular system, as well as common medications such as semaglutide and tirzepatide. The chart also covers injection sites, potential side effects, and dispels common myths about GLP-1 therapies. Ideal for endocrinology clinics, patient education, and classrooms, this chart makes a complex treatment option easy to understand. (BSI2411)